Report of the national heart, lung, and blood institute working group on sex differences research in cardiovascular disease: Scientific questions and challenges

Hypertension

Volumn 67, Issue 5, 2016, Pages 802-807

  Maric Bilkan, Christine ^a   Arnold, Arthur P ^b   Taylor, Doris A ^c   Dwinell, Melinda ^d   Howlett, Susan E ^e,f   Wenger, Nanette ^g   Reckelhoff, Jane F ^h   Sandberg, Kathryn ⁱ   Churchill, Gary ^j   Levin, Ellis ^k   Lundberg, Martha S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TEXAS HEART INSTITUTE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

ⁱ GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^j JACKSON LABORATORY   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BLOOD PRESSURE; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; HEART ARRHYTHMIA; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; IMMUNOMODULATION; IN VITRO STUDY; NATIONAL HEALTH ORGANIZATION; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SEX CHROMOSOME; SEX DIFFERENCE; STEM CELL; T LYMPHOCYTE; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; FEMALE; MALE; MEDICAL RESEARCH; PRACTICE GUIDELINE; QUESTIONNAIRE; SEXUAL DEVELOPMENT; STANDARDS; UNITED STATES;

BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PRACTICE GUIDELINES AS TOPIC; PREVALENCE; SEX CHARACTERISTICS; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84961233476     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06967     Document Type: Review

References (51)

1. Gouni-Berthold I, Berthold HK, Treatment of cardiovascular risk factors in women. Curr Med Chem 2015 22 3580 3596
2. Roger VL, Go AS, Lloyd-Jones DM, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012 125 e2 e220. doi: 10.1161/CIR.0b013e31823ac046
3. GBD 2014 Mortaility and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 385 117 171
4. Taylor KE, Vallejo-Giraldo C, Schaible NS, Zakeri R, Miller VM, Reporting of sex as a variable in cardiovascular studies using cultured cells. Biol Sex Differ 2011 2 11. doi: 10.1186/2042-6410-2-11
5. Clayton JA, Collins FS, Policy: NIH to balance sex in cell and animal studies. Nature 2014 509 282 283
6. Mogil JS, Chanda ML, The case for the inclusion of female subjects in basic science studies of pain. Pain 2005 117 1 5. doi: 10.1016/j.pain.2005.06.020
7. Prendergast BJ, Onishi KG, Zucker I, Female mice liberated for inclusion in neuroscience and biomedical research. Neurosci Biobehav Rev 2014 40 1 5. doi: 10.1016/j.neubiorev.2014.01.001
8. Mahmoodzadeh S, Fliegner D, Dworatzek E, Sex differences in animal models for cardiovascular diseases and the role of estrogen. Handb Exp Pharmacol 2012 23 48
9. Murphy E, Steenbergen C, Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 2007 75 478 486. doi: 10.1016/j.cardiores.2007.03.025
10. Crea F, Battipaglia I, Andreotti F, Sex differences in mechanisms, presentation and management of ischaemic heart disease. Atherosclerosis 2015 241 157 168. doi: 10.1016/j.atherosclerosis.2015.04.802
11. Richardson SS, Reiches M, Shattuck-Heidorn H, LaBonte ML, Consoli T, Opinion: Focus on preclinical sex differences will not address women's and men's health disparities. Proc Natl Acad Sci U S A 2015 112 13419 13420. doi: 10.1073/pnas.1516958112
12. Prinz F, Schlange T, Asadullah K, Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 2011 10 712. doi: 10.1038/nrd3439-c1
13. Nelson WD, Zenovich AG, Ott HC, Stolen C, Caron GJ, Panoskaltsis-Mortari A, Barnes SA 3rd, Xin X, Taylor DA, Sex-dependent attenuation of plaque growth after treatment with bone marrow mononuclear cells. Circ Res 2007 101 1319 1327. doi: 10.1161/CIRCRESAHA.107.155564
14. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG, Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007 204 2449 2460. doi: 10.1084/jem.20070657
15. Ji H, Zheng W, Li X, Liu J, Wu X, Zhang MA, Umans JG, Hay M, Speth RC, Dunn SE, Sandberg K, Sex-specific T-cell regulation of angiotensin II-dependent hypertension. Hypertension 2014 64 573 582. doi: 10.1161/HYPERTENSIONAHA.114.03663
16. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014 129 e28 e292. doi: 10.1161/01.cir.0000441139.02102.80
17. Pollow DP, Uhrlaub J, Romero-Aleshire MJ, Sandberg K, Nikolich-Zugich J, Brooks HL, Hay M, Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension. Hypertension 2014 64 384 390. doi: 10.1161/HYPERTENSIONAHA.114.03581
18. http://www.cdc.gov/nchs/hus.htm. Health, United States, With Special Feature on Death and Dying. Accessed September 15, 2015
19. Lima R, Wofford M, Reckelhoff JF, Hypertension in postmenopausal women. Curr Hypertens Rep 2012 14 254 260. doi: 10.1007/s11906-012-0260-0
20. Kuhar P, Lunder M, Drevensek G, The role of gender and sex hormones in ischemic-reperfusion injury in isolated rat hearts. Eur J Pharmacol 2007 561 151 159. doi: 10.1016/j.ejphar.2007.01.043
21. Wang L, Gu H, Turrentine M, Wang M, Estradiol treatment promotes cardiac stem cell (CSC)-derived growth factors, thus improving CSC-mediated cardioprotection after acute ischemia/reperfusion. Surgery 2014 156 243 252. doi: 10.1016/j.surg.2014.04.002
22. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E, Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res 2010 106 1681 1691. doi: 10.1161/CIRCRESAHA.109.213645
23. Yano M, Yamamoto T, Ikeda Y, Matsuzaki M, Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 2006 3 43 52. doi: 10.1038/ncpcardio0419
24. Xin HB, Senbonmatsu T, Cheng DS, Wang YX, Copello JA, Ji GJ, Collier ML, Deng KY, Jeyakumar LH, Magnuson MA, Inagami T, Kotlikoff MI, Fleischer S, Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002 416 334 338. doi: 10.1038/416334a
25. Dunlay SM, Roger VL, Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure. Curr Heart Fail Rep 2012 9 267 276. doi: 10.1007/s11897-012-0107-7
26. Seeland U, Regitz-Zagrosek V, Sex and gender differences in cardiovascular drug therapy. Handb Exp Pharmacol 2012 211 236
27. Greiten LE, Holditch SJ, Arunachalam SP, Miller VM, Should there be sex-specific criteria for the diagnosis and treatment of heart failure? J Cardiovasc Transl Res 2014 7 139 155. doi: 10.1007/s12265-013-9514-8
28. Murphy E, Estrogen signaling and cardiovascular disease. Circ Res 2011 109 687 696. doi: 10.1161/CIRCRESAHA.110.236687
29. Adlanmerini M, Solinhac R, Abot A, Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci U S A 2014 111 E283 E290. doi: 10.1073/pnas.1322057111
30. Pedram A, Razandi M, Lewis M, Hammes S, Levin ER, Membrane-localized estrogen receptor α is required for normal organ development and function. Dev Cell 2014 29 482 490. doi: 10.1016/j.devcel.2014.04.016
31. Moreno C, Dumas P, Kaldunski ML, Tonellato PJ, Greene AS, Roman RJ, Cheng Q, Wang Z, Jacob HJ, Cowley AW Jr., Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics 2003 15 243 257. doi: 10.1152/physiolgenomics.00105.2003
32. Herrera VL, Pasion KA, Moran AM, Ruiz-Opazo N, Differential genetic basis for pre-menopausal and post-menopausal salt-sensitive hypertension. PLoS One 2012 7 e43160. doi: 10.1371/journal.pone.0043160
33. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT, Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995 9 444 450. doi: 10.1038/ng0495-444
34. Cowley AW Jr, Moreno C, Jacob HJ, Peterson CB, Stingo FC, Ahn KW, Liu P, Vannucci M, Laud PW, Reddy P, Lazar J, Evans L, Yang C, Kurth T, Liang M, Characterization of biological pathways associated with a 1.37 Mbp genomic region protective of hypertension in Dahl S rats. Physiol Genomics 2014 46 398 410. doi: 10.1152/physiolgenomics.00179.2013
35. Haddad R, Kasneci A, Sebag IA, Chalifour LE, Cardiac structure/function, protein expression, and DNA methylation are changed in adult female mice exposed to diethylstilbestrol in utero. Can J Physiol Pharmacol 2013 91 741 749. doi: 10.1139/cjpp-2013-0014
36. Sebag IA, Gillis MA, Calderone A, Kasneci A, Meilleur M, Haddad R, Noiles W, Patel B, Chalifour LE, Sex hormone control of left ventricular structure/function: mechanistic insights using echocardiography, expression, and DNA methylation analyses in adult mice. Am J Physiol Heart Circ Physiol 2011 301 H1706 H1715. doi: 10.1152/ajpheart.00088.2011
37. Jiang D, Zheng D, Wang L, Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PLoS One 2013 8 e59752. doi: 10.1371/journal.pone.0059752
38. Evangelista AM, Deschamps AM, Liu D, Raghavachari N, Murphy E, miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1. Physiol Genomics 2013 45 493 498. doi: 10.1152/physiolgenomics.00008.2013
39. Li J, Chen X, McClusky R, Ruiz-Sundstrom M, Itoh Y, Umar S, Arnold AP, Eghbali M, The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: one X is better than two. Cardiovasc Res 2014 102 375 384. doi: 10.1093/cvr/cvu064
40. Ji H, Zheng W, Wu X, Liu J, Ecelbarger CM, Watkins R, Arnold AP, Sandberg K, Sex chromosome effects unmasked in angiotensin II-induced hypertension. Hypertension 2010 55 1275 1282. doi: 10.1161/HYPERTENSIONAHA.109.144949
41. Barker DJ, Bagby SP, Developmental antecedents of cardiovascular disease: a historical perspective. J Am Soc Nephrol 2005 16 2537 2544. doi: 10.1681/ASN.2005020160
42. Tomat AL, Salazar FJ, Mechanisms involved in developmental programming of hypertension and renal diseases. Gender differences. Horm Mol Biol Clin Investig 2014 18 63 77. doi: 10.1515/hmbci-2013-0054
43. Thornburg KL, O'Tierney PF, Louey S, Review: The placenta is a programming agent for cardiovascular disease. Placenta 2010 31(suppl S54 S59. doi: 10.1016/j.placenta.2010.01.002
44. Barker DJ, Osmond C, Kajantie E, Eriksson JG, Growth and chronic disease: findings in the Helsinki Birth Cohort. Ann Hum Biol 2009 36 445 458. doi: 10.1080/03014460902980295
45. Myatt L, Muralimanoharan S, Maloyan A, Effect of preeclampsia on placental function: influence of sexual dimorphism, microRNA's and mitochondria. Adv Exp Med Biol 2014 814 133 146. doi: 10.1007/978-1-4939-1031-1-12
46. Akhmedov AT, Marín-García J, Mitochondrial DNA maintenance: an appraisal. Mol Cell Biochem 2015 409 283 305. doi: 10.1007/s11010-015-2532-x
47. Jansen RP, Burton GJ, Mitochondrial dysfunction in reproduction. Mitochondrion 2004 4 577 600
48. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G, Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005 353 999 1007. doi: 10.1056/NEJMoa043814
49. Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I, Cignarella A, Bolego C, Plebani M, Nardelli GB, Sartore S, Agostini C, Avogaro A, Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008 28 997 1004. doi: 10.1161/ATVBAHA.107.159558
50. Deasy BM, Lu A, Tebbets JC, Feduska JM, Schugar RC, Pollett JB, Sun B, Urish KL, Gharaibeh BM, Cao B, Rubin RT, Huard J, A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol 2007 177 73 86. doi: 10.1083/jcb.200612094
51. Crisostomo PR, Markel TA, Wang M, Lahm T, Lillemoe KD, Meldrum DR, In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery 2007 142 215 221. doi: 10.1016/j.surg.2007.04.013